Benedikt Schaefer

Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.

Andrea Ardizzoni, H. Hansen, P Dombernowsky et al. · Journal of Clinical Oncology · 1997 · 479 citations

A time-resolved proteomic and prognostic map of COVID-19

Vadim Demichev, Pinkus Tober‐Lau, Oliver Lemke et al. · Cell Systems · 2021 · 212 citations · Full text

Accredited Diagnostic Parameters, Prognosis, Immunology +17

EASL Clinical Practice Guidelines on haemochromatosis

Heinz Zoller, Benedikt Schaefer, Annick Vanclooster et al. · Journal of Hepatology · 2022 · 158 citations · Full text

Laboratory Medicine, Medicine, Laboratory Hematology

Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation

Karim Hamesch, Mattias Mandorfer, Vítor Magno Pereira et al. · Gastroenterology · 2019 · 139 citations · Full text

Metabolic Syndrome, Metabolic Alterations, Fibrosis +11

Choice of High-Dose Intravenous Iron Preparation Determines Hypophosphatemia Risk

Benedikt Schaefer, Philipp Würtinger, Armin Finkenstedt et al. · PLoS ONE · 2016 · 93 citations · Full text